Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

NCT07001592 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
18
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)